Clinical Research CoordinatorCourse 2 of 8

Clinical Research Coordinator

Full course · Study Start-Up and Site Activation

Central IRB vs. local IRB: different processes, same principles — Study Start-Up and Site Activation

Central IRB vs. local IRB: different processes, same principles

Differentiate the submission processes for central IRB review, local IRB review, and institutional-level approvals, and navigate the practical workflow differences that affect your start-up timeline.

25 min

Same study, same city, six weeks apart

Two sites in the same city are participating in the same Phase III trial. Both signed their clinical trial agreements the same week. Both had complete regulatory packages ready to go. Both submitted to their respective IRBs on a Monday.

The first site submitted through the sponsor's designated central IRB--an online portal, a streamlined application that references the already-approved protocol, and a turnaround commitment of seven to 10 business days. Eight days later, the approval letter arrived.

The second site submitted to its academic medical center's institutional IRB. That IRB meets once a month, on the third Thursday. The submission deadline for the next meeting had passed two days earlier. The application sat in queue for three and a half weeks, was reviewed at the following month's meeting, received two stipulations requiring consent form revisions, and was conditionally approved. Final unconditional approval took six weeks from the original submission date.

Same study. Same city. Same regulatory protections for participants. But the coordinator at Site One was preparing for the site initiation visit while the coordinator at Site Two was still waiting for the first IRB meeting.

This is not a story about one model being better than the other. Both IRBs fulfilled their regulatory mandate--reviewing the study for participant protection before authorizing enrollment. The difference is entirely operational: different processes, different timelines, different workflows for the coordinator. And understanding those differences is essential, because as a coordinator you will encounter both models, sometimes simultaneously on different studies, and you need to navigate each one without letting process confusion delay your start-up timeline.

What you will learn4 objectives

By the end of this lesson, you will be able to:

Explain the single IRB mandate under NIH policy and the FDA regulatory framework, including when single IRB review is required and the exceptions that permit local IRB review
Describe the central IRB model, including reliance agreements, institutional profiles, local context information, and the coordinator's role in a streamlined submission process
Describe the local IRB model, including complete submission packages, committee meeting schedules, and direct communication with IRB staff
Navigate the practical workflow differences between central and local IRB processes, including submission portals, communication channels, amendment procedures, and continuing review requirements

Progress saves itself — finish reading and this lesson completes

This is just the beginning

Same study, same city, six weeks apart